Try our Advanced Search for more refined results

June 12, 2014

VIVUS, INC. v. ACTAVIS LABORATORIES FL, INC.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. July 06, 2017

    Actavis Reaches Deal With Vivus Over Obesity Drug Patents

    Vivus Inc. said Wednesday it reached a deal to end its patent suit against Teva Pharmaceuticals Inc. unit Actavis over its formula for obesity treatment drug Qsymia, closing a three-year row over six different patents.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login